APAC Clinical Diagnostics Market 2021-2031 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "APAC Clinical Diagnostics Market 2021-2031" report has been added to ResearchAndMarkets.com's offering.

Asia Pacific clinical diagnostics market will grow by 9.8% annually with a total addressable market cap of $257.46 billion over 2022-2031, driven by the rising patient awareness and rising demand for high-quality care, growing healthcare spend, technological advancement, benefits of clinical diagnostics such as quick test results and easy procedure, increasing prevalence of chronic diseases caused due to sedentary lifestyle such as diabetes, cardiovascular diseases, high blood pressure, lipid disorders, kidney diseases and cancer.

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter's Five Forces

Based on Test, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Lipid Panel
• Infectious Disease Testing
• Liver Panel
• Complete Blood Count (CBC)
• Electrolyte Testing
• Renal Panel
• Other Tests

Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Instruments
• Assay Kits & Reagents
• Software & Services

By Indication the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Cardiovascular
• Cancer
• Infectious Disease
• Stroke
• Chronic Lower Respiratory Diseases
• Diabetes
• Other Indications

By Patient Gender the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Male Patients
• Female Patients

By Age Group the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Age 44 and below
• Age 45-64
• Age 65 and over

By End User the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

• Hospital & Clinics Laboratory
• Diagnostic Laboratory
• Point-of-Care Testing
• Other End Users

For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of key national markets by Test, Product, and Indication, over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

• Abbott Laboratories
• Becton, Dickinson and Company
• BioMerieux SA
• Bio-Rad Laboratories Inc.
• Bio-Reference Laboratories
• Bioscientia Healthcare
• Charles River Laboratories
• Danaher Corporation
• Hoffmann-La Roche AG
• Hologic Inc.
• Qiagen NV
• Siemens Healthcare
• Thermo Fisher Scientific

Key Topics Covered:

1 Introduction

2 Market Overview and Dynamics

3 Segmentation of Asia Pacific Market by Test

3.1 Market Overview by Test

3.2 Lipid Panel

3.3 Infectious Disease Testing

3.4 Liver Panel

3.5 Complete Blood Count (CBC)

3.6 Electrolyte Testing

3.7 Renal Panel

3.8 Other Tests

4 Segmentation of Asia Pacific Market by Product

4.1 Market Overview by Product

4.2 Instruments

4.3 Assay Kits & Reagents

4.4 Software & Services

5 Segmentation of Asia Pacific Market by Indication

5.1 Market Overview by Indication

5.2 Cardiovascular

5.3 Cancer

5.4 Infectious Disease

5.5 Stroke

5.6 Chronic Lower Respiratory Diseases

5.7 Diabetes

5.8 Other Indications

6 Segmentation of Asia Pacific Market by Patient Gender

6.1 Market Overview by Patient Gender

6.2 Male Patients

6.3 Female Patients

7 Segmentation of Asia Pacific Market by Age Group

7.1 Market Overview by Age Group

7.2 Age 44 and below

7.3 Age 45-64

7.4 Age 65 and over

8 Segmentation of Asia Pacific Market by End User

8.1 Market Overview by End User

8.2 Hospital & Clinics Laboratory

8.3 Diagnostic Laboratory

8.4 Point-of-Care Testing

8.5 Other End Users

9 Asia-Pacific Market 2021-2031 by Country

For more information about this report visit https://www.researchandmarkets.com/r/s85el1